Literature DB >> 15643000

Serological specificities of murine hybridoma monoclonal antibodies against Neisseria meningitidis serogroups B, C, Y, and W135 and evaluation of their usefulness as serogrouping reagents by indirect whole-cell enzyme-linked immunosorbent assay.

Raymond S W Tsang1, Wendell D Zollinger.   

Abstract

Murine hybridoma monoclonal antibodies (MAbs) were produced against the capsular antigens of serogroups B, C, Y, and W135 meningococci. Each serogroup-specific MAb reacted with the extracted capsular polysaccharide from its homologous serogroup only and did not react with capsules from the other three serogroups. The application of these MAbs for serogroup identification of meningococci was demonstrated by their abilities to correctly identify 183 clinical isolates of 185 meningococci recovered from individual invasive meningococcal disease (IMD) patients during routine surveillance in 2002. The remaining two meningococci were identified by PCR grouping as C in one case and Y in another, but neither isolate was positive by bacterial agglutination using rabbit antisera or by enzyme-linked immunosorbent assay using MAbs. The specificities of the anti-Y and anti-W135 MAbs were further assessed by tests with 37 serogroup W135 and 106 serogroup Y meningococci recovered from IMD cases during 1999 to 2001 and 2003. All 143 meningococci except one serogroup Y isolate were correctly identified by positive reactions with the corresponding MAbs that identified their homologous serogroups. The single serogroup Y isolate was received as nonagglutinable and tested as negative with both rabbit anti-Y antiserum and anti-Y MAb but was positive for the serogroup Y-specific siaD gene. The advantage of using MAbs for serogrouping of meningococci is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15643000      PMCID: PMC540207          DOI: 10.1128/CDLI.12.1.152-156.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  29 in total

Review 1.  Meningococcal disease.

Authors:  N E Rosenstein; B A Perkins; D S Stephens; T Popovic; J M Hughes
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

2.  Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada, January 1, 1999 to June 30, 2001.

Authors:  Raymond Sw Tsang; Susan G Squires; Wendell D Zollinger; Fraser E Ashton
Journal:  Can J Infect Dis       Date:  2002-11

Review 3.  Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience.

Authors:  E A Kirsch; R P Barton; L Kitchen; B P Giroir
Journal:  Pediatr Infect Dis J       Date:  1996-11       Impact factor: 2.129

4.  Measurement of antibodies to meningococcal group B polysaccharide: low avidity binding and equilibrium binding constants.

Authors:  R E Mandrell; W D Zollinger
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

5.  Serological characterization.

Authors:  B Kuipers; G van den Dobbelsteen; E Wedege; L van Alphen
Journal:  Methods Mol Med       Date:  2001

6.  siaD PCR ELISA for confirmation and identification of serogroup Y and W135 meningococcal infections.

Authors:  R Borrow; H Claus; U Chaudhry; M Guiver; E B Kaczmarski; M Frosch; A J Fox
Journal:  FEMS Microbiol Lett       Date:  1998-02-15       Impact factor: 2.742

7.  Production of polyclonal and monoclonal antibodies against group A, B, and C capsular polysaccharides of Neisseria meningitidis and preparation of latex reagents.

Authors:  F Nato; J C Mazie; J M Fournier; B Slizewicz; N Sagot; M Guibourdenche; D Postic; J Y Riou
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

8.  Bactericidal activity of two IgG2a murine monoclonal antibodies with distinct fine specificities for group B Neisseria meningitidis capsular polysaccharide.

Authors:  C M Hurpin; E D Carosella; P A Cazenave
Journal:  Hybridoma       Date:  1992-12

9.  Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis.

Authors:  Elizabeth A Mothershed; Claudio T Sacchi; Anne M Whitney; Gwen A Barnett; Gloria W Ajello; Susanna Schmink; Leonard W Mayer; Maureen Phelan; Thomas H Taylor; Scott A Bernhardt; Nancy E Rosenstein; Tanja Popovic
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

Review 10.  Meningococcal disease: still with us.

Authors:  H Peltola
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb
View more
  8 in total

1.  Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada.

Authors:  Raymond S W Tsang; Averil M Henderson; Marissa L Cameron; Shaun D Tyler; Shari Tyson; Dennis K S Law; Jan Stoltz; Wendell D Zollinger
Journal:  J Clin Microbiol       Date:  2007-04-18       Impact factor: 5.948

2.  Serotyping and population genetics of invasive Haemophilus influenzae.

Authors:  Raymond S W Tsang
Journal:  J Clin Microbiol       Date:  2008-03       Impact factor: 5.948

3.  International circumpolar surveillance interlaboratory quality control program for serotyping Haemophilus influenzae and serogrouping Neisseria meningitidis, 2005 to 2009.

Authors:  Raymond S W Tsang; Karen Rudolph; Marguerite Lovgren; Sadjia Bekal; Brigitte Lefebvre; Lotte Lambertsen; Tammy Zulz; Michael Bruce
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

4.  The conformational properties of methyl alpha-(2,8)-di/trisialosides and their N-acyl analogues: implications for anti-Neisseria meningitidis B vaccine design.

Authors:  Austin B Yongye; Jorge Gonzalez-Outeiriño; John Glushka; Verena Schultheis; Robert J Woods
Journal:  Biochemistry       Date:  2008-11-25       Impact factor: 3.162

5.  Epitope specificities of the group Y and W-135 polysaccharides of Neisseria meningitidis.

Authors:  Samuel L Moore; Catherine Uitz; Chang-Chun Ling; David R Bundle; Peter C Fusco; Francis Michon
Journal:  Clin Vaccine Immunol       Date:  2007-09-05

6.  New rapid diagnostic tests for Neisseria meningitidis serogroups A, W135, C, and Y.

Authors:  Suzanne Chanteau; Sylvie Dartevelle; Ali Elhadj Mahamane; Saacou Djibo; Pascal Boisier; Farida Nato
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

7.  Storage and stability of IgG and IgM monoclonal antibodies dried on filter paper and utility in Neisseria meningitidis serotyping by Dot-blot ELISA.

Authors:  Aline S Ferraz; Elza F T Belo; Ligia M C C Coutinho; Ana P Oliveira; Andréia M S Carmo; Daniele L Franco; Tatiane Ferreira; André Y Yto; Marta S F Machado; Monica C G Scola; Elizabeth De Gaspari
Journal:  BMC Infect Dis       Date:  2008-03-06       Impact factor: 3.090

8.  A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A.

Authors:  Jacopo Enotarpi; Marta Tontini; Cristiana Balocchi; Daan van der Es; Ludovic Auberger; Evita Balducci; Filippo Carboni; Daniela Proietti; Daniele Casini; Dmitri V Filippov; Hermen S Overkleeft; Gijsbert A van der Marel; Cinzia Colombo; Maria Rosaria Romano; Francesco Berti; Paolo Costantino; Jeroen D C Codeé; Luigi Lay; Roberto Adamo
Journal:  Nat Commun       Date:  2020-09-07       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.